Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
23,995,349
-
Share change
-
+12,617,278
-
Total reported value
-
$186,221,799
-
Price per share
-
$7.76
-
Number of holders
-
75
-
Value change
-
+$97,624,858
-
Number of buys
-
56
-
Number of sells
-
11
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q2 2020
As of 30 Jun 2020,
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,995,349 shares.
The largest 10 holders included
BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P., EcoR1 Capital, LLC, SV Health Investors, LLC, Samsara BioCapital, LLC, BAILLIE GIFFORD & CO, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.